Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator

Seetha Bhagavan, Dolores Ibarreta, Dawei Ma, Alan P. Kozikowski, René Etcheberrigaray

Research output: Contribution to journalArticle

Abstract

Several alterations in fibroblasts of Alzheimer's disease (AD) patients have been described, including alterations in calcium regulation, protein kinase C (PKC), and potassium (K+) channels. Studies have also found reduced levels of the α isoform of PKC in brains and fibroblasts of AD patients. Since PKC is known to regulate ion channels, we studied K+ channel activity in fibroblasts from AD patients in the presence of (2S, 5S)-8-(1- decynyl)benzolactam (BL), a novel activator of PKC with improved selectivity for the α, β, and γ isoforms. We present evidence for restoration of normal K+ channel function, as measured by TEA-induced [Ca2+](i) elevations, due to activation of PKC by BL. Representative patch-clamp data further substantiate the effect of BL on restoration of 113pS K+ channel activity. Immunoblotting analyses using an α-isozyme-specific PKC antibody confirm that BL-treated fibroblasts of AD patients show increased PKC activation. The present study suggests that PKC activator-based restoration of K+ channels may offer another approach to the investigation of AD pathophysiology, which in turn could lead to the development of a useful model for AD therapeutics.

Original languageEnglish (US)
Pages (from-to)177-187
Number of pages11
JournalNeurobiology of Disease
Volume5
Issue number3
DOIs
StatePublished - Sep 1998
Externally publishedYes

Fingerprint

Protein Kinase C
Alzheimer Disease
Fibroblasts
Calcium
Protein Isoforms
Potassium Channels
Ion Channels
Immunoblotting
Isoenzymes
Antibodies
Brain

Keywords

  • Alzheimer's disease
  • Calcium
  • Fibroblast
  • Protein kinase C
  • TEA

ASJC Scopus subject areas

  • Neurology

Cite this

Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator. / Bhagavan, Seetha; Ibarreta, Dolores; Ma, Dawei; Kozikowski, Alan P.; Etcheberrigaray, René.

In: Neurobiology of Disease, Vol. 5, No. 3, 09.1998, p. 177-187.

Research output: Contribution to journalArticle

Bhagavan, Seetha ; Ibarreta, Dolores ; Ma, Dawei ; Kozikowski, Alan P. ; Etcheberrigaray, René. / Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator. In: Neurobiology of Disease. 1998 ; Vol. 5, No. 3. pp. 177-187.
@article{8652cb469cb7492784d0dbb166372c2c,
title = "Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator",
abstract = "Several alterations in fibroblasts of Alzheimer's disease (AD) patients have been described, including alterations in calcium regulation, protein kinase C (PKC), and potassium (K+) channels. Studies have also found reduced levels of the α isoform of PKC in brains and fibroblasts of AD patients. Since PKC is known to regulate ion channels, we studied K+ channel activity in fibroblasts from AD patients in the presence of (2S, 5S)-8-(1- decynyl)benzolactam (BL), a novel activator of PKC with improved selectivity for the α, β, and γ isoforms. We present evidence for restoration of normal K+ channel function, as measured by TEA-induced [Ca2+](i) elevations, due to activation of PKC by BL. Representative patch-clamp data further substantiate the effect of BL on restoration of 113pS K+ channel activity. Immunoblotting analyses using an α-isozyme-specific PKC antibody confirm that BL-treated fibroblasts of AD patients show increased PKC activation. The present study suggests that PKC activator-based restoration of K+ channels may offer another approach to the investigation of AD pathophysiology, which in turn could lead to the development of a useful model for AD therapeutics.",
keywords = "Alzheimer's disease, Calcium, Fibroblast, Protein kinase C, TEA",
author = "Seetha Bhagavan and Dolores Ibarreta and Dawei Ma and Kozikowski, {Alan P.} and Ren{\'e} Etcheberrigaray",
year = "1998",
month = "9",
doi = "10.1006/nbdi.1998.0195",
language = "English (US)",
volume = "5",
pages = "177--187",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator

AU - Bhagavan, Seetha

AU - Ibarreta, Dolores

AU - Ma, Dawei

AU - Kozikowski, Alan P.

AU - Etcheberrigaray, René

PY - 1998/9

Y1 - 1998/9

N2 - Several alterations in fibroblasts of Alzheimer's disease (AD) patients have been described, including alterations in calcium regulation, protein kinase C (PKC), and potassium (K+) channels. Studies have also found reduced levels of the α isoform of PKC in brains and fibroblasts of AD patients. Since PKC is known to regulate ion channels, we studied K+ channel activity in fibroblasts from AD patients in the presence of (2S, 5S)-8-(1- decynyl)benzolactam (BL), a novel activator of PKC with improved selectivity for the α, β, and γ isoforms. We present evidence for restoration of normal K+ channel function, as measured by TEA-induced [Ca2+](i) elevations, due to activation of PKC by BL. Representative patch-clamp data further substantiate the effect of BL on restoration of 113pS K+ channel activity. Immunoblotting analyses using an α-isozyme-specific PKC antibody confirm that BL-treated fibroblasts of AD patients show increased PKC activation. The present study suggests that PKC activator-based restoration of K+ channels may offer another approach to the investigation of AD pathophysiology, which in turn could lead to the development of a useful model for AD therapeutics.

AB - Several alterations in fibroblasts of Alzheimer's disease (AD) patients have been described, including alterations in calcium regulation, protein kinase C (PKC), and potassium (K+) channels. Studies have also found reduced levels of the α isoform of PKC in brains and fibroblasts of AD patients. Since PKC is known to regulate ion channels, we studied K+ channel activity in fibroblasts from AD patients in the presence of (2S, 5S)-8-(1- decynyl)benzolactam (BL), a novel activator of PKC with improved selectivity for the α, β, and γ isoforms. We present evidence for restoration of normal K+ channel function, as measured by TEA-induced [Ca2+](i) elevations, due to activation of PKC by BL. Representative patch-clamp data further substantiate the effect of BL on restoration of 113pS K+ channel activity. Immunoblotting analyses using an α-isozyme-specific PKC antibody confirm that BL-treated fibroblasts of AD patients show increased PKC activation. The present study suggests that PKC activator-based restoration of K+ channels may offer another approach to the investigation of AD pathophysiology, which in turn could lead to the development of a useful model for AD therapeutics.

KW - Alzheimer's disease

KW - Calcium

KW - Fibroblast

KW - Protein kinase C

KW - TEA

UR - http://www.scopus.com/inward/record.url?scp=0031797871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031797871&partnerID=8YFLogxK

U2 - 10.1006/nbdi.1998.0195

DO - 10.1006/nbdi.1998.0195

M3 - Article

VL - 5

SP - 177

EP - 187

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

IS - 3

ER -